NCT03585452View on ClinicalTrials.gov

Effects of Dexmedetomidine on Cognitive Outcome and Brain Injury Markers

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

December 30, 2018

Study Completion Date

March 31, 2019

Conditions
Cognitive Dysfunction
Interventions
DRUG

Dexmedetomidine Infusion

Patients with additional dexmedetomidine infusion

DRUG

Propofol based general anesthesia

Patients with typical anaesthetic regimens

Trial Locations (1)

20-867

Michał Kowalczyk, Lublin

All Listed Sponsors
lead

Michał Kowalczyk

OTHER

NCT03585452 - Effects of Dexmedetomidine on Cognitive Outcome and Brain Injury Markers | Biotech Hunter | Biotech Hunter